Benjamin Looker

Insider Reports History

Entity
Individual
Location
C/O Trillium Therapeutics Inc., 2488 Dunwin Drive, Mississauga, Ontario, Canada
Signature
/s/ Sheldon L. Koenig, by power of attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Benjamin Looker:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Esperion Therapeutics, Inc. General Counsel Common Stock 184K $104K $1.25 Mar 14, 2024 Direct
Esperion Therapeutics, Inc. General Counsel Stock Option (right to buy) 150K Mar 14, 2024 Direct
Trillium Therapeutics Inc. General Counsel Stock Option (Right to Buy) 0 Nov 17, 2021 Direct

Insider Reports Filed by Benjamin Looker

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ESPR Esperion Therapeutics, Inc. Mar 14, 2024 2 $0 4 Mar 15, 2024 General Counsel
ESPR Esperion Therapeutics, Inc. Apr 19, 2023 1 -$1.64K 4 Apr 20, 2023 General Counsel
ESPR Esperion Therapeutics, Inc. Mar 14, 2023 2 $0 4 Mar 15, 2023 General Counsel
ESPR Esperion Therapeutics, Inc. Jan 18, 2023 1 -$44.4K 4 Jan 19, 2023 General Counsel
ESPR Esperion Therapeutics, Inc. Jun 7, 2022 1 $0 4 Jun 9, 2022 General Counsel
ESPR Esperion Therapeutics, Inc. Jan 27, 2022 2 $0 4 Jan 28, 2022 General Counsel
ESPR Esperion Therapeutics, Inc. Jan 1, 2022 0 $0 3 Jan 4, 2022 General Counsel
TRIL Trillium Therapeutics Inc. Nov 17, 2021 1 $0 4 Nov 19, 2021 General Counsel